Branda buys MRK 59.2: Merckâs Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review in Europe for the Treatment of Advanced Mel ...
WHITEHOUSE STATION, N.J., Jun 30, 2014 (BUSINESS WIRE) -- Merck (NYSE:MRK) , known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA ... ...
32 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home